Dirk Beher
Chief Executive Officer
business
ASCENEURON
Netherlands
Biography
Dirk Beher is the Chief Executive Officer, a Founder and a Member of the Board of Directors of Asceneuron SA. Since its inception he has strategically positioned Asceneuron as an emerging leader in the field of orally bioavailable drugs for treating tauopathies. Under his leadership the company has raised to date over CHF 40 million from leading venture capital firms and successfully moved a novel modifier of tau pathology into the clinic. Dirk brings more than 25 years of experience in the field of Alzheimer's disease / neurodegeneration and spent over 19 years in pharmaceutical drug discovery including senior research positions around the globe at Merck Sharp & Dohme (Merck & Co.), Amgen and Merck KGaA. Dirk holds a Ph.D. and a Diploma (M.S.) in Biology from the Ruprecht-Karls University Heidelberg, Germany. He is an inventor of seven patents and author of 49 peer-reviewed publications and reviews.
Research Interest
